BCAX

Bicara Therapeutics Inc. Common StockNASDAQHealthcare

$21.47+4.73%ClosedMarket Cap: $1.18B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-31	Goldman Sachs	—	Neutral	—
2026-03-31	Wells Fargo	—	Equal Weight	—
2026-03-31	Citizens	—	Market Outperform	—
2026-03-31	HC Wainwright & Co.	—	Buy	—
2026-03-31	Wedbush	—	Outperform	—
2026-01-13	Wedbush	—	Outperform	—
2025-11-11	Wells Fargo	—	Equal Weight	—
2025-08-22	HC Wainwright & Co.	—	Buy	—
2025-05-23	Wells Fargo	—	Equal Weight	—
2025-05-16	HC Wainwright & Co.	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Thu Dec 31	$-2.94	$0.00	10
Fri Dec 31	$-3.22	$0.00	10
Sun Dec 31	$-2.87	$94.9M	8
Mon Dec 31	$-0.46	$407.8M	6